Quince Therapeutics (QNCX) Invested Capital (2023 - 2025)

Quince Therapeutics' Invested Capital history runs 3 years deep, the most recent figure standing at $11.8 million for Q4 2025.

• In Q4 2025, Invested Capital changed N/A year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $35.2 million (up 604.48% YoY), while the FY2025 annual figure was $11.8 million, changed N/A from the prior year.
• Invested Capital for Q4 2025 stood at $11.8 million, roughly flat from $11.7 million in the prior quarter.
• The five-year high for Invested Capital was $11.8 million in Q4 2025, with the low at $5.0 million in Q2 2024.
• The 3-year median for Invested Capital is $11.4 million (2023), against an average of $10.4 million.
• Peak annual rise in Invested Capital reached 134.4% in 2025, while the deepest fall reached 134.4% in 2025.
• Quince Therapeutics' Invested Capital stood at $11.1 million in 2023, then plunged by 54.76% to $5.0 million in 2024, then jumped by 135.12% to $11.8 million in 2025.
• Business Quant data shows QNCX's Invested Capital at $11.8 million in Q4 2025, $11.7 million in Q3 2025, and $11.7 million in Q2 2025.